The Government of Quebec has offered a financial contribution of $31 million to the Montreal Clinical Research Institute (IRCM) to support its operations and research activities until 2023-2024.
The IRCM intends to use this investment to enable “scientists and clinicians to continue working on a host of hopeful advances,” assured Jean-François Côté, interim president and scientific director of the IRCM.
“From the laboratory to the patient, the work of the IRCM, for more than half a century, has beneficial spinoffs for the population of Quebec and beyond. Today, we would like to express our complete gratitude for this important grant,” he said in a press release.
The IRCM is an independent biomedical research center affiliated with the Université de Montréal and associated with McGill University and the Center hospitalier de l’Université de Montréal (CHUM). It provides researchers with state-of-the-art technological infrastructure to “accelerate the acquisition of new knowledge and the development of innovative therapeutic avenues”, particularly for diseases such as cancer, cardiovascular and metabolic diseases and neurological disorders.
“As a major player in clinical and basic research in Quebec, the IRCM shares the commitment we made in our Health Plan, namely to make Quebec a more innovative and efficient society in this area. To transform, our health and social services system must think and do things differently, and therefore take up the challenge of innovation,” said Minister of Health and Social Services Christian Dubé, who was in Montreal on Monday in company of the Minister of Economy and Innovation and Minister responsible for Regional Economic Development, Pierre Fitzgibbon, to announce this investment.
